| Previous close | 9.12 |
| Open | 9.12 |
| Bid | 8.15 |
| Ask | 8.45 |
| Strike | 20.00 |
| Expiry date | 2024-10-18 |
| Day's range | 9.12 - 9.12 |
| Contract range | N/A |
| Volume | |
| Open interest | 689 |
Investor's Business DailyNovavax Stock Rocketed This Year, But Challenges Persist. Is It A Buy Or A Sell?
Novavax stock remains volatile. After hitting a two-year high in June on enthusiasm for its updated Covid vaccine, shares have pulled back.
Investor's Business DailyIs Novavax Stock A Buy Or A Sell In September 2024 On A Mixed Earnings Report?
Novavax stock rose on its strong earnings, though sales came in light and the company cut its outlook. Is NVAX stock a buy or a sell?
PR NewswireNovavax 2024-2025 Formula COVID-19 Vaccine Available at Major Pharmacies Across the U.S.
Novavax, Inc. (Nasdaq: NVAX), a global company advancing protein-based vaccines with its Matrix-M™ adjuvant, today announced that doses of the Novavax COVID-19 Vaccine, Adjuvanted (2024-2025 Formula) (NVX-CoV2705) to prevent COVID-19 in individuals aged 12 and older are in stock at major pharmacy retailers across the U.S.
© 2024 Yahoo. All rights reserved.